Insilico Medicine Public Corporations

Insilico Medicine is a global AI-driven biotechnology company specializing in accelerating drug discovery with generative AI and deep learning. It applies AI platforms to design novel therapeutics and advance clinical programs.

Invests into

Investors

Connections

Connections from

Industry: BioMed
Super Industry: Organization
Headquarters: Hong Kong
Founded Date: 2014
Employee Number: ~350
Register and Claim Ownership